BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 193526)

  • 1. On the rise in low density and high density lipoproteins in response to the treatment of hypertriglyceridaemias in type IV and type V hyperlipoproteinaemias.
    Carlson LA; Olsson G; Ballantyne D
    Atherosclerosis; 1977 Apr; 26(4):603-9. PubMed ID: 193526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of clofibrate on lipoprotein-lipids in patients with type IV hyperlipoproteinaemia (author's transl)].
    Weisweiler P; Schwandt P
    Klin Wochenschr; 1977 Aug; 55(16):791-4. PubMed ID: 198601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of clofibrate, nicotinic acid and diet on the properties of the plasma lipoproteins in a subject with type III hyperlipoproteinemia.
    Patsch JR; Yeshurun D; Jackson RL; Gotto AM
    Am J Med; 1977 Dec; 63(6):1001-9. PubMed ID: 204188
    [No Abstract]   [Full Text] [Related]  

  • 4. One-year study of the effect of bezafibrate on serum lipoprotein concentrations in hyperlipoproteinaemia.
    Olsson AG; Lang PD
    Atherosclerosis; 1978 Dec; 31(4):429-33. PubMed ID: 215175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of hyperlipidemia.
    Levy RI; Morganroth J; Rifkind BM
    N Engl J Med; 1974 Jun; 290(23):1295-301. PubMed ID: 4363888
    [No Abstract]   [Full Text] [Related]  

  • 6. Type III hyperlipoproteinemia: rise in high-density lipoprotein levels in response to therapy.
    Falko JM; Witztum JL; Schonfeld G; Weidman SW; Kolar JB
    Am J Med; 1979 Feb; 66(2):303-10. PubMed ID: 218451
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of nicotinic acid therapy on plasma lipoproteins and very low density lipoprotein apoprotein C subspecies in hyperlipoproteinemia.
    Yovos JG; Patel ST; Falko JM; Newman HA; Hill DS
    J Clin Endocrinol Metab; 1982 Jun; 54(6):1210-5. PubMed ID: 7076797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversion of type III hyperlipoproteinaemia to type IV hyperlipoproteinaemia by a fat-free, carbohydrate rich diet.
    Vessby B; Carlson LA
    Eur J Clin Invest; 1975 Jul; 5(4):359-64. PubMed ID: 170119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein composition and lipoprotein interrelations in 50-year-old men with hyperlipoproteinaemia.
    Vessby B; Hedstrand H; Olsson U
    Ups J Med Sci; 1976; 81(2):71-8. PubMed ID: 183321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
    Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
    Artery; 1982; 10(4):266-85. PubMed ID: 7181672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-response study of bezafibrate on serum lipoprotein concentrations in hyperlipoproteinanemia.
    Olsson AG; Lang PD
    Atherosclerosis; 1978 Dec; 31(4):421-8. PubMed ID: 215174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative trial of clofibrate and nicotinyl alcohol tartrate in hyperlipoproteinemic patients.
    Dujovne CA; Azarnoff DL; Pentikainen P; Manion CV; Hurwitz A
    Am J Med Sci; 1979; 277(3):255-61. PubMed ID: 222145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Familial hyperlipoproteinemia type III].
    Patsch JR; Patsch W; Sailer S; Braunsteiner H
    Dtsch Med Wochenschr; 1976 Oct; 101(44):1612-9. PubMed ID: 185039
    [No Abstract]   [Full Text] [Related]  

  • 14. Dietary and drug treatment of primary hyperlipoproteinemia.
    Ann Intern Med; 1972 Aug; 77(2):267-94. PubMed ID: 4345081
    [No Abstract]   [Full Text] [Related]  

  • 15. Type IV hyperlipoproteinaemia.
    Kwiterovich PO; Margolis S
    Clin Endocrinol Metab; 1973 Mar; 2(1):41-71. PubMed ID: 4359117
    [No Abstract]   [Full Text] [Related]  

  • 16. The concentration of high density lipoprotein in patients with type IV hyperlipoproteinemia and the effect of clofibrate.
    Brook JG; Lavy A; Aviram M; Zinder O
    Atherosclerosis; 1980 Aug; 36(4):461-9. PubMed ID: 7417365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative treatment of hyperlipoproteinaemias in chimpanzees.
    Vastesaeger M; Blaton V; Declercq B; Vercruysse J; Vandamme D; Peeters H; Mortelmans J
    Acta Zool Pathol Antverp; 1974; 58(0):79-96. PubMed ID: 4365833
    [No Abstract]   [Full Text] [Related]  

  • 18. Clofibrate and related compounds in hyperlipoproteinaemia. A review.
    Gustafson A
    Postgrad Med J; 1975; 51(8):suppl 66-71. PubMed ID: 215983
    [No Abstract]   [Full Text] [Related]  

  • 19. Metabolic relationships among the plasma lipoproteins. Reciprocal changes in the concentrations of very low and low density lipoproteins in man.
    Wilson DE; Lees RS
    J Clin Invest; 1972 May; 51(5):1051-7. PubMed ID: 4341500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of gemfibrozil and clofibrate on metabolism of cholesterol and plasma triglycerides in man.
    Kesäniemi YA; Grundy SM
    JAMA; 1984 May; 251(17):2241-6. PubMed ID: 6368883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.